Susquehanna International Group, LLP Simulations Plus, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$38.46 - $50.95 $504,518 - $668,362	13,118 New	13,118 $637,000
Q4 2023 Feb 14, 2024	BUY	$33.36 - $45.71 $39,331 - $53,892	1,179 Added 24.39%	6,012 $269,000
Q3 2023 Nov 14, 2023	SELL	$40.03 - $51.51 $153,555 - $197,592	-3,836 Reduced 44.25%	4,833 $201,000
Q2 2023 Aug 11, 2023	SELL	$40.45 - $48.0 $235,095 - $278,976	-5,812 Reduced 40.14%	8,669 $375,000
Q1 2023 May 16, 2023	BUY	$34.96 - $43.94 $310,409 - $390,143	8,879 Added 158.5%	14,481 $636,000
Q4 2022 Feb 14, 2023	BUY	$36.55 - $51.15 $23,282 - $32,582	637 Added 12.83%	5,602 $204,000
Q3 2022 Nov 14, 2022	BUY	$47.75 - $66.88 $237,078 - $332,059	4,965 New	4,965 $241,000
Q4 2021 Feb 14, 2022	SELL	$37.1 - $57.45 $32,833 - $50,843	-885 Reduced 8.83%	9,132 $432,000
Q2 2021 Aug 11, 2021	BUY	$49.67 - $68.96 $15,348 - $21,308	309 Added 3.18%	10,017 $550,000
Q1 2021 May 17, 2021	SELL	$60.06 - $89.52 $507,206 - $755,996	-8,445 Reduced 46.52%	9,708 $614,000
Q4 2020 Feb 16, 2021	SELL	$53.26 - $77.18 $21,623 - $31,335	-406 Reduced 2.19%	18,153 $1.31 Million
Q3 2020 Nov 16, 2020	BUY	$57.51 - $75.36 $28,122 - $36,851	489 Added 2.71%	18,559 $1.4 Million
Q2 2020 Aug 14, 2020	BUY	$32.91 - $59.82 $259,923 - $472,458	7,898 Added 77.64%	18,070 $1.08 Million
Q1 2020 May 15, 2020	SELL	$26.79 - $38.99 $158,355 - $230,469	-5,911 Reduced 36.75%	10,172 $355,000
Q4 2019 Feb 14, 2020	SELL	$29.07 - $35.63 $97,762 - $119,823	-3,363 Reduced 17.29%	16,083 $468,000
Q3 2019 Nov 14, 2019	BUY	$28.19 - $41.75 $548,182 - $811,870	19,446 New	19,446 $675,000

Others Institutions Holding SLP

# of Institutions

175

Shares Held

15.1M

Call Options Held

5.4K

Put Options Held

1.4K

View Full List

About Simulations Plus, Inc.

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $584M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

More about SLP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account